Multiple Sclerosis Patient Experience on Kesimpta and Ocrevus Subcutaneous Formulation

Inclusion Criteria

• •1. Ability to use a mobile device or computer with broadband internet access (or data streaming available)
• •2. Ability to read, understand, and respond in English
• •3. Adult aged 18 years of age or over at the time of the survey
• •4. Self-confirmed diagnosis of MS
• •5. Prescribed either OMB or OCR SC and will receive their first injection (Day 0) followed by completing the study survey between Day 1 and Day 7